Eugene Myron Holuka is Director of Citius Pharmaceuticals, Inc.. Currently has a direct ownership of 2,367 shares of CTXR, which is worth approximately $6,887. The most recent transaction as insider was on Mar 13, 2024, when has been sold 48 shares (Common Stock) at a price of $0.75 per share, resulting in proceeds of $36. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.37K
0% 3M change
n/a 12M change
Total Value Held $6,887

Eugene Myron Holuka Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 13 2024
SELL
Payment of exercise price or tax liability
$36 $0.75 p/Share
48 Reduced 1.99%
2,367 Common Stock
Mar 13 2024
BUY
Exercise of conversion of derivative security
$48 $0.02 p/Share
2,415 Added 50.0%
2,415 Common Stock

Also insider at

TENK
TenX Keane Acquisition
EMH

Eugene Myron Holuka

Director
Cranford, NJ

Track Institutional and Insider Activities on CTXR

Follow Citius Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTXR shares.

Notify only if

Insider Trading

Get notified when an Citius Pharmaceuticals, Inc. insider buys or sells CTXR shares.

Notify only if

News

Receive news related to Citius Pharmaceuticals, Inc.

Track Activities on CTXR